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Colistin resistance genes mcr-3 and mcr-1 have been 
detected in an Escherichia coli isolate from cat-
tle faeces in a Spanish slaughterhouse in 2015. The 
sequences of both genes hybridised to same plasmid 
band of ca 250 kb, although colistin resistance was 
non-mobilisable. The isolate was producing extended-
spectrum beta-lactamases and belonged to serotype 
O9:H10 and sequence type ST533. Here we report 
an mcr-3 gene detected in Europe following earlier 
reports from Asia and the United States.
Very recently, in June 2017, Yin et al. detected a third 
mobile colistin resistance gene mcr-3 on an IncHI2-type 
plasmid, pWJ1, in a porcine E. coli isolate from Malaysia 
[1]. The authors also identified similar elements in a 
shotgun genome sequence of a human Klebsiella pneu-
moniae isolate from Thailand and a human Salmonella 
enterica serovar Typhimurium isolate from the United 
States [1].
We found an Escherichia coli isolate carrying the mcr-3 
gene among other isolates expressing colistin resist-
ance. It was sampled in cattle faeces at the time of 
slaughter in Spain in September 2015. The aim of this 
paper is to describe the presence of mcr-3 in Europe in 
a strain also carrying the mcr-1 gene. 
Screening of bovine samples for colistin-
resistant bacteria 
The VISAVET Health Surveillance Centre in Madrid 
has been carrying out the national surveillance for 
detection of extended-spectrum beta-lactamase 
(ESBL)-producing bacteria in food-producing animals 
since 2014, commissioned by the Spanish Ministry of 
Agriculture and Fishing, Food and Environment accord-
ing to Commission Implementing Decision 2013/652/
EU [2]. The screening was performed at slaughter-
houses during 2015 on healthy cattle younger than one 
year from 318 farms (caecal content of 636 animals). 
The procedure followed the EURL-AR recommendations 
for detecting ESBL-producing E. coli [3]. 
A total of 152 samples (47.8%) were suspected to be 
positive, so antimicrobial susceptibility testing was 
performed by Sensititre microbroth dilution using 
EUVSEC and EUVSEC2 plates (Trek Diagnostic Systems, 
US) to confirm their beta-lactamase production. The 
antimicrobial drugs to be included in each panel are 
detailed in the Commission Implementing Decision 
2013/652/EU [2]. Six E. coli isolates were found resist-
ant to colistin and further characterised. Among them, 
five were PCR-positive for mcr-1 [4] and one isolate 
(ZTA15/01169–1EB1) was also PCR-positive for mcr-3 
[1]. All isolates presented multi-resistant phenotypes 
(Table 1) and lacked the mcr-2 gene [5].
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Both mcr-1 and mcr-3 genes were detected by PCR using 
previously described primers and conditions [1,4]. 
Minimal inhibitory concentrations were determined 
by using the two-fold broth microdilution reference 
method according to ISO 20776–1:2006 [6]. The inter-
pretation of the quantitative data was performed as 
described by the Commission Implementing Decision 
2013/652/EU [2], EURL-AR (the EU Reference Laboratory 
for antimicrobial resistance in the context of animal 
health and food safety) and The European Committee 
on Antimicrobial Susceptibility Testing (EUCAST) [7]. 
The isolate ZTA15/01169–1EB1 carrying both mcr-1 and 
mcr-3 was resistant to most antimicrobial drugs ana-
lysed, including ampicillin, azithromycin, cefepime, 
cefotaxime, ceftazidime, chloramphenicol, ciprofloxa-
cin, colistin, gentamicin, nalidixic acid, sulfamethoxa-
zole, tetracycline and trimethoprim. The isolate was 
sensitive to carbapenems, cefoxitin, temocillin and 
tigecyclin (Table 1).
Characterisation of the mcr-1 and mcr-3 
Escherichia coli isolate 
DNA from isolate ZTA15/01169–1EB1 was extracted 
with the QIAGEN DNeasy Blood and Tissue Kit and 
sequencing libraries were prepared using the Nextera 
XT kit and sequenced on a MiSeq (Illumina) using v3 
reagents with 2 x 300 cycles. This isolate produced 
547,226 reads that were assembled using SPAdes v 
3.9.0 [8]. The draft genome of 5,115,727 bp was com-
posed by 495 contigs (N50 = 23,843, 29X coverage) and 
genome annotation was performed by using Prokka 
[9]. The profiles of serotype O9:H10, ST533, rST 30316, 
cgST 47043 and wgST 49795 were predicted by using 
EnteroBase (http://enterobase.warwick.ac.uk). The 
resistome of the draft genome was analysed by blastn 
[10] searches against the ResFinder database [11]. The 
presence of putative plasmids was evaluated by blastn 
searches against the PlasmidFinder database, reveal-
ing 100% identity to sequence probes from IncHI2 and 
IncI1 replicons (Table 2) [12]. Both colistin resistance 
genes carried by isolate ZTA15/01169–1EB1, mcr-1 and 
mcr-3, are plasmidic and have been associated with 
HincHI2 plasmids [1,13].
mcr-1 was found in a 2,074 bp-length contig, and 
blastn comparison against the National Center for 
Biotechnology Information (NCBI) database [14] 
revealed best match with the IncHI2-type plasmid 
pECJS-59–244 previously described [13]. mcr-3 was 
found in a 4,098 bp-length contig, and blastn of the 
gene showed 100% coverage (1–1626/1626) and 
99,94% nucleotide identity to mcr-3. A unique polymor-
phism (C1463T) was found in its coding sequence, giv-
ing rise to a T488I variant of the protein encoded by this 
gene allele, hereafter named mcr-3.2. Moreover, isolate 
ZTA15/01169–1EB1 contained the mutations S83L and 
D87N of GyrA, in complete concordance with the phe-
notypic results (Table 1), in addition to two beta-lac-
tamase-encoding genes (blaCTX-M-55 and blaTEM-1) 
and several other resistance determinants (Table 2). 
CTX-M is a widely spread ESBL that could be encoded 
by IncHI2 and HincI1, among other plasmids [13].
Plasmid location of the mcr-1 and mcr-3.2 genes from 
isolate ZTA15/01169–1EB1 was evidenced by nucle-
ase S1 digestion and pulsed-field gel electrophoresis 
(PFGE), followed by transfer of DNA to nylon membranes 
and hybridisation to Dig-labelled probes (Sigma, US). 
Specific signals obtained by using probes for both 
mcr-1 and mcr-3, matched a plasmid band of ca 250 kb 
(Figure). Specificity of the mcr-1 probe was evidenced 
by using a previously characterised strain carrying 
mcr-1 on a 30 kb IncX4 plasmid [15]. A second ca 75 kb 
plasmid was identified by PFGE in isolate ZTA15/01169–
1EB1 (Figure). However, despite the plasmidic location 
of the mcr-1 and mcr-3.2 genes, colistin resistance was 
not mobilisable by conjugation in standard conditions 
(overnight mating at 37 °C) to the receptor strain E. coli 
Figure 
S1 nuclease mapping of mcr-1 and mcr-3.2 genes in 
Escherichia coli ZTA15/01169–1EB1, Spain, September 
2015
A. PFGE was performed in a Bio-Rad CHEF-DRII electrophoresis 
system, and agarose plugs were prepared according to 
manufacturer instructions. XbaI and S1 nuclease treatments 
were performed as previously described [17]. Lane 1: XbaI-
digested Salmonella Braenderup; Lanes 2 and 3: S1 nuclease-
digested E. coli ZTA15/01169 at 1× (108 cells/mL plug) and 3× 
concentration, respectively; Lane 4: S1 nuclease-digested 
E. coli HSP38 (carrying mcr-1 by IncX4 plasmid) [15]; Lane 5: 
Saccharomyces cerevisiae chromosomes as a second molecular 
weight marker (Bio-Rad, US).
B. Southern hybridisation to Dig-labelled probes (Sigma, US) from 
mcr-1 sequences.
C. Southern hybridisation to Dig-labelled probes (Sigma, US) from 
mcr-3 sequences.
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J53 after selection in medium with sodium azide (100 
mg/L) and colistin (2 mg/L). The previously described 
E. coli isolate ZTA14/01057 was used as a positive con-
trol in parallel, and conjugation to the same recipient 
was successful with 4.2·10−2 efficiency [16].
Discussion and conclusions
The first plasmid-mediated polymyxin resistance 
mechanism, mcr-1, was reported in 2016 by Liu et al. 
in human E. coli and K. pneumoniae collected from five 
provinces in China between April 2011, and November 
2014 [4]. A second resistance gene, mcr-2, was identi-
fied in porcine and bovine E. coli in Belgium in June 2016 
[5], and as recently as in June 2017, Yin et al. reported 
the finding of the third gene, mcr-3, in a porcine E. coli 
isolate from Malaysia and two humans isolates of K. 
pneumoniae and S. enterica serovar Typhimurium from 
Thailand and the United States, respectively [1]. We 
also demonstrated in 2016 the presence of mcr-1 in 
E. coli and S. enterica isolates from poultry and swine 
in Spain [15]. In addition to these findings, this work 
describes the results of screening for multidrug-resist-
ant E. coli (including polymyxin resistance) of bovine 
origin in Spain. Among the colistin-resistant isolates 
found, three genotypes were identified: strains carry-
ing mcr-1 alone, strains carrying mcr-1 and mcr-3.2, and 
strains without any plasmidic determinants. This study 
shows the appearance of the colistin-resistant mcr-3 
gene in Europe as early as in 2015, as well as the coex-
istence of two plasmid-mediated colistin resistance 
genes, mcr-1 and mcr-3.2 in the same cells of isolate 
ZTA15/01169–1EB1.
Table 1
Colistin resistance genes and antimicrobial resistance of Escherichia coli isolates of bovine origin, Spain, September 2015 
(n = 6)
ZTA15/ 
01169–1EB1
ZTA15/ 
00213–1EB1
ZTA15/ 
00579–1EB1
ZTA15/ 
01425–1EB1
ZTA15/ 
01928–1EB1
ZTA15/ 
02163–1EB1
Presence of mcr gene
mcr-1  Yes No   Yes Yes Yes Yes
mcr-3   Yes No No No No No
Antimicrobial resistance (minimal inhibitory concentrations)
COL 4 (R) 4 (R) 4 (R) 4 (R) 4 (R) 4 (R)
CIP > 8 (R) 8 (R) > 8 (R) > 8 (R) 8 (R) 8 (R)
NAL > 128 (R) > 128 (R) > 128 (R) > 128 (R) > 128 (R) > 128 (R)
AMP > 64 (R) > 64 (R) > 64 (R) > 64 (R) > 64 (R) > 64 (R)
FEP > 32 (R) 4 (R) > 32 (R) 16 (R) > 32 (R) 16 (R)
FOT > 4 (R) > 4 (R) > 4 (R) > 4 (R) > 4 (R) > 4 (R)
FOT2 > 64 (R) 16 (R) > 64 (R) 64 (R) > 64 (R) > 64 (R)
FOX 4 16 (R) 8 8 4 4
TAZ > 8 (R) > 8 (R) 8 (R) 4 (R) 8 (R) 8 (R)
TAZ2 8 (R) 128 (R) 16 (R) 4 (R) 8 (R) 8 (R)
TRM 16 16 8 8 8 ≤ 4
ETP 0.03 ≤ 0.015 0.03 0.03 0.06 0.03
IMI ≤ 0.12 ≤ 0.12 ≤ 0.12 0.25 0.25 0.25
MER ≤ 0.03 ≤ 0.03 ≤ 0.03 ≤ 0.03 ≤ 0.03 ≤ 0.03
MER2 ≤ 0.03 ≤ 0.03 ≤ 0.03 ≤ 0.03 ≤ 0.03 ≤ 0.03
AZI 64 (R) 64 (R) 8 4 ≤ 2 ≤ 2
CHL > 128 (R) 128 (R) 128 (R) 32 (R) 8 128 (R)
GEN > 32 (R) ≤ 0.5 ≤ 0.5 ≤ 0.5 ≤ 0.5 ≤ 0.5
TET > 64 (R) 64 (R) 32 (R) > 64 (R) 64 (R) > 64 (R)
SMX > 1,024 (R) > 1,024 (R) > 1,024 (R) > 1,024 (R) > 1,024 (R) > 1,024 (R)
TMP > 32 (R) 0.5 > 32 (R) > 32 (R) > 32 (R) > 32 (R)
TGC ≤ 0.25 ≤ 0.25 ≤ 0.25 ≤ 0.25 ≤ 0.25 ≤ 0.25
AMP: ampicillin; AZI: azithromycin; CHL: chloramphenicol; CIP: ciprofloxacin; COL: Colistin; ETP: ertapenem; FEP: Cefepime; FOT/FOT2: 
cefotaxime; FOX: cefoxitin; GEN: gentamicin; IMI: imipenem; MER/MER2: meropenem; NAL: nalidixic acid; SMX: sulfamethoxazole; TAZ/TAZ2: 
ceftazidime; TET: tetracycline; TGC: tigecyclin; TMP: trimethoprim; TRM: temocillin.
Antibiotics are ordered according to importance/clinical impact in food-producing animals.
Resistance is indicated by (R).
mcr-1 and mcr-3 genes were detected by PCR using previously described primers and conditions [1,4]. Minimal inhibitory concentrations 
were determined by using the two-fold broth microdilution reference method according to ISO 20776–1:2006 [6]. The interpretation of the 
quantitative data was performed as described by the Commission Implementing Decision 2013/652/EU [2], EURL-AR (EU Reference Laboratory 
for antimicrobial resistance in the context of animal health and food safety) and EUCAST (The European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) [7]. 
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Whole genome sequencing of isolate ZTA15/01169–
1EB1 revealed mcr-1 upstream a complete PAP2 gene in 
a 2,074 bp contig that showed 99.96% coverage and 
100% identity to the IncHI2-type plasmid pECJS-59–244 
(243,572 bp; 10). The mcr-3.2 gene was positioned in a 
4,098 bp contig, sharing 100% coverage and 99.94% 
identity with the mcr-3 gene located in the IncHI2-type 
plasmid pWJ1 (261,119 nt) previously described [1].
Most mcr-1, mcr-2 and mcr-3 genes are plasmidic 
sequences [1,4,5]. Although the PFGE and further 
hybridisation with mcr-1- and mcr-3-specific probes did 
not exclude the possibility of independent carriage by 
two different similar-sized plasmids, genome sequenc-
ing of isolate ZTA15/01169–1EB1 only identified the 
IncHI2 replicon as an appropriate candidate to harbour 
colistin resistance genes. We therefore assume that 
both genes were located on the same plasmid in our 
isolate.
Further efforts are focused on investigating the struc-
ture of plasmids, transmission potential, gene expres-
sion and stability of the mcr-1 and mcr-3.2 genes. 
Furthermore, the reason why co-occurrence of mcr-1 
and mcr-3 genes confers low colistin resistance needs 
to be elucidated.
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